Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
about
Screening for nasopharyngeal cancerEBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas.Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for fieTwo-step Epstein-Barr virus immunoglobulin A enzyme-linked immunosorbent assay system for serological screening and confirmation of nasopharyngeal carcinomaChildhood cancers: what is a possible role of infectious agents?Humoral immune responses to Epstein-Barr virus encoded tumor associated proteins and their putative extracellular domains in nasopharyngeal carcinoma patients and regional controls.Dried-blood sampling for epstein-barr virus immunoglobulin G (IgG) and IgA serology in nasopharyngeal carcinoma screening.Clinical values of multiple Epstein-Barr virus (EBV) serological biomarkers detected by xMAP technology.Complementary determination of Epstein-Barr virus DNA load and serum markers for nasopharyngeal carcinoma screening and early detection in individuals at risk in Tunisia.Nasopharyngeal cancer-derived microRNA-21 promotes immune suppressive B cellsTumor microenvironment contributes to Epstein-Barr virus anti-nuclear antigen-1 antibody production in nasopharyngeal carcinoma.Over-expression of miR-10b in NPC patients: correlation with LMP1 and Twist1.Two Epstein-Barr virus-related serologic antibody tests in nasopharyngeal carcinoma screening: results from the initial phase of a cluster randomized controlled trial in Southern China.An efficacy analysis for nasopharyngeal carcinoma screening of different screening intervals.Assessment of the Long-term Diagnostic Performance of a New Serological Screening Scheme in Large-scale Nasopharyngeal Carcinoma Screening.
P2860
Q24187937-6B72266C-DD57-41B8-8171-BF69645C349CQ24804219-DB2DC71A-9776-494D-9422-6F20E38148BEQ33239049-84A356C2-7D47-41F1-A882-C36B4991A265Q33422245-6137227C-0B5F-4370-925C-9B35C0C3BF2AQ33643064-9DC658B4-C199-408D-91B2-8D88CA8AF87CQ33822681-AF011CC4-FBCD-43B9-B8C6-F32A1D3FB0F7Q36539838-4A3B9EA3-5DBE-42B7-B464-8CAA9DB1C8F9Q37325545-3BD6C827-60C1-4003-935E-A12A7574A385Q38888811-22B3D255-317F-4ADD-8243-30D80FBA31EFQ38924980-45C4A31A-C237-4D06-A7D8-0414B6E4DF1CQ40092870-452D7FEE-2F92-41F7-8671-68ADF45A3D83Q42174718-D02D639D-1D9A-4DF4-8DAC-E8110283C41CQ44562504-E4C0E371-9635-4EB2-A706-34FE29DE6DDBQ51184991-649EF904-0C6F-4716-B3C9-912A58ABAF9CQ55280881-7E90A3B2-F3CD-499F-AB40-990A9D52BBAF
P2860
Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Comparison of three different ...... n two age groups from Tunisia.
@en
Comparison of three different ...... n two age groups from Tunisia.
@nl
type
label
Comparison of three different ...... n two age groups from Tunisia.
@en
Comparison of three different ...... n two age groups from Tunisia.
@nl
prefLabel
Comparison of three different ...... n two age groups from Tunisia.
@en
Comparison of three different ...... n two age groups from Tunisia.
@nl
P2093
P356
P1476
Comparison of three different ...... in two age groups from Tunisia
@en
P2093
P2860
P304
P356
10.1002/JMV.20310
P577
2005-04-01T00:00:00Z